The Effect of Brief Crisis Intervention Package on Improving Quality of Life and Mental Health in Patients with COVID-19

Abstract

Objective: COVID 19 is having a devastating effect on mankind’s life. Individuals with COVID-19 will experience high levels of stress, depression, anxiety, and low quality of life. The goals the of present study were to investigate the effect of brief crisis intervention package on stress, depression, anxiety, and quality of life in patient with COVID-19.
 Method: In this randomized controlled clinical trial, 30 patients were randomly selected and divided into control and experimental groups. The experimental group was examined in four 60-minute sessions for one month. During this period, the control group received only routine treatment and therapy. Before and after the intervention, DASS21, the Symptom Checklist (SCL-25), and WHO-QOL were used to measure and record patient mental health and quality of life. Finally, data were analyzed using SPSS 24 software.
 Results: The average mental health score was assessed with WHO-QOL, DASS21, and SCL-25 before intervention and was not statistically significant (P = > 0.05), and the mean score of stress, anxiety, depression, WHO-QOL, SCL-25 after intervention was statistically significant (P < 0.001). Therefore, results showed the brief crisis intervention package was effective in improving the quality of life (P < 0.05) and mental illnesses (P < 0.05) in patients with COVID-19.
 Conclusion: The brief crisis intervention package can reduce the negative effect of patients with COVID-19. Therefore, this intervention can be used as a beneficial treatment to improve mental disorder symptoms and to improve the condition of people who suffer from COVID-19.

The effectiveness of psychological support interventions for those exposed to mass infectious disease outbreaks: a systematic review

“…• The Intervention significantly improved symptoms of: • Anxiety ( adjusted standardised mean differences ) (− 0.26; 95% CI-0.45 to − 0.08; p = .004); • Stress ( adjusted standardised mean differences ) (− 0.30; 95% CI − 0.50 to − 0.09; p = .003); • PTSD ( adjusted standardised mean differences ) (− 0.20; 95% CI-0.37 to − 0.03; p = 0.01) • No significant differences were observed for symptoms of depression. Gharaati Sotoudeh, 2020 (RCT) [ 39 ] Iran; Hospital Patients with diagnosis of COVID-19 ( N = 30) ( n = 16 intervention group; n = 14 control group): 53.3% female; age range: 20 to 70 years; mean age Intervention Group: 41.92 years (SD: 12.2 years); mean age Control Group: 44.7 years (SD: 14.2 years). Brief Crisis Intervention Package.…”

“…One study was published in 2006 [ 46 ]. Studies were conducted in several different countries: Belgium ( n = 1) [ 53 ], Canada ( n = 1) [ 45 ], China ( n = 6) [ 40 – 44 , 56 ], Hong Kong ( n = 1) [ 46 ], Iran ( n = 3) [ 39 , 48 , 51 ], Italy ( n = 3) [ 36 , 49 , 50 ], Oman ( n = 1) [ 35 ], Serbia ( n = 1) [ 54 ], Spain ( n = 1) [ 38 ], Sweden ( n = 1) [ 55 ], and Turkey ( n = 2) [ 37 , 47 ]. One study [ 52 ] involved participants from seven different countries (Australia, Canada, France, Mexico, Spain, UK and USA).…”

“…One study [ 52 ] involved participants from seven different countries (Australia, Canada, France, Mexico, Spain, UK and USA). Nine of these studies’ countries were high-income countries (HICs) [ 35 , 36 , 38 , 45 , 46 , 49 , 50 , 53 , 55 ] and 12 were upper-middle-income countries (UMICs) [ 37 , 39 – 44 , 47 , 48 , 51 , 54 , 56 ]. One study was conducted in countries from both HIC and UMIC [ 52 ].…”

“…Eleven studies involved participants who were patients, of which: seven involved patients with COVID-19 [ 39 , 40 , 42 – 44 , 47 , 48 ]; three with pre-existing chronic diseases exposed to COVID-19 and / or with a diagnosis of COVID-19 [ 41 , 52 , 53 ]; and one involved adult patients with chronic diseases exposed to SARS [ 46 ].…”

A Short-term Psychological Intervention for People Living with HIV During the First Wave of COVID-19

“…Pre-pandemic research supports the effectiveness of cognitive-behavior therapy for treating depression in people living with HIV (Lofgren et al, 2018 ) and also of telephone-delivered interventions for overcoming barriers to participating in psychotherapy among people with HIV (Moitra et al, 2020 ). Although specific interventions for COVID-related psychological distress in at-risk groups have been described, evidence to date of their uptake and efficacy at reducing symptoms has been limited to a handful of studies conducted almost exclusively in health care workers (Blake et al, 2020 ; Cheng et al, 2020 ; Geoffroy et al, 2020 ; Sanadgol et al, 2020 ) or patients with COVID-19 (Gharaati Sotoudeh et al, 2020 ; Li et al, 2020 ; Liu et al, 2020 ; Shaygan et al, 2020 ; Wei et al, 2020 ; Zhou et al, 2020 ).…”